| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Suzanne Heywood is Director at CNH, with reported holdings spanning 2 companies. Suzanne Heywood's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $7.6M at current prices.
Our model assigns Suzanne Heywood a middling insider score of 50/100, based on 3 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +6.5%.
Suzanne Heywood's largest disclosed position is in CNH as Director, worth about $7.4M. Net of sales, the CNH filings show accumulation of 17,256 shares.
Suzanne Heywood has 10 Form 4 filings on record from May 2024 to May 2026, across 2 companies: Director at CNH Industrial (CNH), 2025–2026; Director at Clarivate (CLVT), 2024–2026.
The 14 reported transactions were 4 stock awards, 3 tax withholdings, 2 option or other derivative awards and 2 option exercises, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $500K and 2 sales worth about $422K.
The only open-market purchase was 52,522 shares of CNH at an average $9.52 on November 18, 2025, about $500K.
The largest open-market sale was 24,213 shares of CNH at an average $11.64 on March 4, 2025, about $282K. Twelve months later CNH was up 1%.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.